Inverse correlation between the formation of mitochondria-derived vacuoles and Lewy-body-like hyaline inclusions in G93A superoxide-dismutase-transgenic mice

Acta Neuropathologica
Hisae SumiSaburo Sakoda

Abstract

In G93A mice, the most popular model of amyotrophic lateral sclerosis (ALS), neuronal Lewy-body-like hyaline inclusions (LBHIs) and mitochondria-derived vacuoles are observed in addition to motor neuron loss. Although LBHIs are thought to be toxic, the significance of the mitochondria-derived vacuoles has not been fully investigated. In this study, the relationship between the formation of these vacuoles and LBHIs was clarified statistically in the lumbar segment from two phyletic lines of G93A mice (G1L, G1H), using immunohistochemical methods. Furthermore, the distributions of vacuoles and LBHIs were examined in the pons including the facial nucleus, where pathological changes occur in ALS patients and G93A mice. Numerous vacuoles 2-3 microm in diameter were detected in the neuropil of the lumbar segment from G1L mice euthanatized approximately 3.5 months prior to the onset of the disease. Most of the vacuoles disappeared, but some became larger as the disease progressed. The number of vacuoles with a diameter exceeding 5 microm began to decrease after disease onset, while that of intra-neuritic LBHIs increased rapidly. There was a strong inverse correlation between the numbers of vacuoles and LBHIs in symptomatic mice (P<0.0...Continue Reading

References

Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Oct 14, 1981·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·S McHanwell, T J Biscoe
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
May 1, 1997·Journal of Neuropathology and Experimental Neurology·H D DurhamD A Figlewicz
Oct 6, 1997·Neuroreport·P BarnéoudP Moser
Dec 29, 1998·The Journal of Cell Biology·J A JohnstonR R Kopito
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·J A JohnstonR R Kopito
Dec 2, 2000·Nature Medicine·D W Cleveland, J Liu
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·S KatoE Ohama
Oct 27, 2001·Neuropathology and Applied Neurobiology·B StephensR J Guiloff
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·David S HowlandJeffrey D Rothstein
Nov 30, 2002·Neuroscience Letters·Christine Haenggeli, Ann C Kato
Apr 25, 2003·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Kimiko InoueSaburo Sakoda
May 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·P B StathopulosE M Meiering
Jan 23, 2004·Experimental Neurology·Lindsey R FischerJonathan D Glass

❮ Previous
Next ❯

Citations

Jan 9, 2008·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Koji DoiTakao Inoué
Apr 7, 2010·Annual Review of Neuroscience·Kevin C KanningChristopher E Henderson
May 5, 2011·Disease Models & Mechanisms·Abraham Acevedo-ArozenaElizabeth M C Fisher
Jul 18, 2009·Muscle & Nerve·Livia PasqualiFrancesco Fornai
Apr 1, 2016·Acta Neuropathologica Communications·Hisae Sumi-AkamaruHideki Mochizuki
Sep 30, 2017·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Hisae Sumi-AkamaruHideki Mochizuki

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.